Establishment of mice model with human viral hepatitis B

World Journal of Gastroenterology

Volumn 10, Issue 6, 2004, Pages 841-846

  Gao, Li Fen ^a   Sun, Wen Shen ^a   Ma, Chun Hong ^a   Liu, Su Xia ^a   Wang, Xiao Yan ^a   Zhang, Li Ning ^a   Cao, Ying Lin ^a   Zhu, Fa Liang ^a   Liu, Yu Gang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HEPATITIS B; HISTOPATHOLOGY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIRUS GENOME;

EID: 1842483166     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i6.841     Document Type: Article

References (35)

1. Ryu WS. Molecular aspects of hepatitis B viral infection and the viral carcinogenesis. J Biochem Mol Biol 2003; 36: 138-143
2. Ke WM, Ye YN, Huang S. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J Gastroenterol 2003; 38: 861-864
3. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7: 208-215
4. Wu JM, Lin JS, Chen BT, Zheng XM, Zhao HB, Liang KH. Establishment and identification of highly expressing and replicating hepatitis B virus genome transgenic mouse models. Zhonghua Ganzangbing Zazhi 2003; 11: 338-340
5. Wieland SF, Vega RG, Muller R, Evans CF, Hilbush B, Guidotti LG, Sutcliffe JG, Schultz PG, Chisari FV. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 2003; 77: 1227-1236
6. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002; 76: 10702-10707
7. Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986; 47: 37-47
8. Marinos G, Torre F, Chokshi S, Hussain M, Clarke BE, Rowlands DJ, Eddleston AL, Naoumov NV, Williams R. Induction of T-helper cell response to hepatitis B:A major factor in activation of the host immune response to the hepatitis B virus. Heptology 1995; 22: 1040-1049
9. Guidotti LG. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection. Vaccine 2002; 20: A80-82
10. Liu DX. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C. Med Hypotheses 2001; 56: 405-408
11. Sun J, Hou JL, Xiao L, Wang ZH, Luo KX. Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application. Zhonghua Shiyan He Linchuang Bingdu Xue Zazhi 2003; 17: 18-20
12. Muchmore EA. Chimpanzee models for human disease and immunobiology. Immunol Rev 2001; 183: 86-93
13. Cooper A, Paran N, Shaul Y. The earliest steps in hepatitis B virus infection. Biochim Biophys Acta 2003; 1614: 89-96
14. Chang SF, Netter HJ, Hildt E, Schuster R, Schaefer S, Hsu YC, Rang A, Will H. Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol 2001; 75: 161-170
15. Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, Yaniv M, McLachlan A. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 2001; 75: 2900-2911
16. Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 1985; 230: 1160-1163
17. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985; 230: 1157-1160
18. Guidotti LG, Matzke B, Schaller H, Chisari FV. High level -hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158-6169
19. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-334
20. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 1541-1554
21. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E. Immunostimulatory DNA sequences function as T-helper-1-promoting adjuvants. Nat Med 1997; 3: 849-854
22. Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158: 3635-3639
23. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248: 361-364
24. Tang TJ, Kwekkeboom J, Iaman JD, Niesters HG, Zondervan PE, De Man RA, Schalm SW, Janssen HL. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J Viral Hepat 2003; 10: 159-167
25. Kasahara S, Ando K, Saito K, Sekikawa K, Ito H, Ishikawa T, Ohnishi H, Seishima M, Kakumu S, Moriwaki H. Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol 2003; 77: 2469-2476
26. Sobao Y, Sugi K, Tomiyama H, Saito S, Fujiyama S, Morimoto M, Hasuike S, Tsubouchi H, Tanaka K, Takiguch M. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A2402, the most common HLA class I allele in East Asia. J Hepatol 2001; 34: 922-929
27. Roh S, Lee YK, Ahn BY, Kim K, Moon A. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses. Virus Res 2001; 73: 17-26
28. Street M, Herd K, Londono P, Doan T, Dougan G, Kast WM, Tindle RW. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region. Arch Virol 1999; 144: 1323-1343
29. Prugnaud JL. DNA vaccines. Ann Pharm Fr 2003; 61: 219-233
30. Wang J, Murakami T, Yoshida S, Matsuoka H, Ishii A, Tanaka T, Tobita K, Ohtsuki M, Nakagawa H, Kusama M, Kobayashi E. Predominant cell-mediated immunity in the oral mucosa: gene gun-based vaccination against infectious diseases. J Dermatol Sci 2003; 31: 203-210
31. Isaguliants MG, Petrakova NV, Mokhonov VV, Pokrovskaya K, Suzdaltzeva YG, Krivonos AV, Zaberezhny AD, Garaev MM, Smirnov VD, Nordenfelt E. DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus. Immunol Lett 2003; 88: 1-13
32. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science 1990; 247(4949 Pt 1): 1465-1468
33. Corr M, von Damm A, Lee DJ, Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer. J Immunol 1999; 163: 4721-4727
34. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39: 222-230
35. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9: 641-644